MINDCURE Announces Additional Equity Investment in ATMA, The First Government Approved Psychedelic Journey Centers In Canada; MCUR President and CEO, Kelsey Ramsden Named to ATMA Board of Directors
Retrieved on:
Thursday, April 8, 2021
Additionally, MINDCURE President and CEO Kelsey Ramsden will be joining the ATMA Board of Directors.
Key Points:
- Additionally, MINDCURE President and CEO Kelsey Ramsden will be joining the ATMA Board of Directors.
- "We are extremely excited to strengthen our partnership with the team at ATMA through this investment.
- ATMA's team is a true pioneer in the psychedelic therapy industry by growing a global network of group and retreat psychedelic therapy clinics," said Kelsey Ramsden, President and CEO, MINDCURE.
- "We are thrilled today to welcome a visionary leader like Kelsey to our Board of Directors," said Vu Tran, Co-CEO of ATMA.